Published August 9, 2018 | Version v1
Journal article Open

ANovel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNAof Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic AcidDiethyl Amide or LSD), Δ9–Tetrahydrocannabinol (THC) [(–)–trans–Δ⁹–Tetrahydrocannabinol],Theobromine (Xantheose),Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV)[Azidothymidine (AZT)] as Anti–Cancer Nano Drugs by Coassembly of DualAnti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistance.

Authors/Creators

  • 1. Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA.
  • 2. Laboratory of Biophysics and Molecular Modeling Genesis, State Secretariat of Education of Paraná, Bela Vista do Paraíso, Paraná, 86130-000, Brazil.

Description

The aim of the present study was to reduce toxicities and to improve bioavailabilities of DNA/RNA of human cancer cells–containing Cocaine (Coke), Lysergide (Lysergic Acid Diethyl Amide or LSD), Δ9–Tetrahydrocannabinol (THC) [(–)–trans–Δ⁹–Tetrahydrocannabinol], Theobromine (Xantheose), Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV) [Azidothymidine (AZT)] as anti–cancer Nano drugs by coassembly of dual anti–cancer Nano drugs to inhibit DNA/RNA of human cancer cells drug resistance.

Files

PJSE, v.4 n.6 9 (1-17) August 9, 2018. Heidari & Gobato.pdf

Files (288.1 kB)